Health Affairs, 26, no. 5 (2007): w630-w643 (Published online 21 August 2007) doi: 10.1377/hlthaff.26.5.w630 © 2007 by Project HOPE	New Online   House Health Reform Bill   Paying for Reform   Vetting AHIP's Report   HIV/AIDS Costs   Brief: Insurance Reform   HA Blog Top 10

This Article Figures Only Full Text (HTML) Reprint (PDF) Online Exhibit Interview With The Author Submit a response to this article Comments: View responses Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Neuman, P. Articles by Safran, D. G. Search for Related Content PubMed PubMed Citation Articles by Neuman, P. Articles by Safran, D. G. Related Collections Access To Care Health Reform Managed Care - Medicare Medicare Pharmaceuticals Chronic Care Health Spending Consumer Issues Elderly

Web Exclusives

MARKETWATCH

Medicare Prescription Drug Benefit Progress Report: Findings From A 2006 National Survey Of Seniors

A national survey in 2006 found that Part D secured drug coverage for most seniors who were without it in 2005, prior to the Medicare drug benefit. Seniors without drug coverage in 2006 generally fell into two groups: those in relatively good health and those potentially difficult to reach. Compared with seniors covered through employer plans or the Department of Veterans Affairs, Part D enrollees had higher out-of-pocket spending and greater cost-related nonadherence. Low-income subsidies offered protection against high out-of-pocket spending; without them, one-third of Part D enrollees at or below 150 percent of poverty paid more than $100 a month for their medications.

                      What's this?

This article has been cited by other articles:

				G. F. Riley, J. M. Levy, and M. A. Montgomery Adverse Selection In The Medicare Prescription Drug Program Health Aff., November 1, 2009; 28(6): 1826 - 1837. [Abstract] [Full Text] [PDF]

				P. Neuman and J. Cubanski Medicare Part D Update -- Lessons Learned and Unfinished Business N. Engl. J. Med., July 23, 2009; 361(4): 406 - 414. [Full Text] [PDF]

				J. M. Donohue, H. A. Huskamp, and S. H. Zuvekas Dual Eligibles With Mental Disorders And Medicare Part D: How Are They Faring? Health Aff., May 1, 2009; 28(3): 746 - 759. [Abstract] [Full Text] [PDF]

				J. R. Cummings, T. Rice, and Y. Hanoch Who Thinks That Part D Is Too Complicated?: Survey Results on the Medicare Prescription Drug Benefit Med Care Res Rev, February 1, 2009; 66(1): 97 - 115. [Abstract] [PDF]

				M. Gold Medicare's Private Plans: A Report Card On Medicare Advantage Health Aff., January 1, 2009; 28(1): w41 - w54. [Abstract] [Full Text] [PDF]

				A. D. Federman, D. G. Safran, S. Keyhani, A. L. Siu, and E. A. Halm Low Levels of Awareness of Pharmaceutical Cost-Assistance Programs Among Inner-City Seniors JAMA, September 24, 2008; 300(12): 1412 - 1414. [Full Text] [PDF]

				S. B. Soumerai, F. Zhang, D. Ross-Degnan, D. E. Ball, R. F. LeCates, M. R. Law, T. E. Hughes, D. Chapman, and A. S. Adams Use Of Atypical Antipsychotic Drugs For Schizophrenia In Maine Medicaid Following A Policy Change Health Aff., May 1, 2008; 27(3): w185 - w195. [Abstract] [Full Text] [PDF]

				J. M. Madden, A. J. Graves, F. Zhang, A. S. Adams, B. A. Briesacher, D. Ross-Degnan, J. H. Gurwitz, M. Pierre-Jacques, D. G. Safran, G. S. Adler, et al. Cost-Related Medication Nonadherence and Spending on Basic Needs Following Implementation of Medicare Part D JAMA, April 23, 2008; 299(16): 1922 - 1928. [Abstract] [Full Text] [PDF]

				J. Hsu, V. Fung, M. Price, J. Huang, R. Brand, R. Hui, B. Fireman, and J. P. Newhouse Medicare Beneficiaries' Knowledge of Part D Prescription Drug Program Benefits and Responses to Drug Costs JAMA, April 23, 2008; 299(16): 1929 - 1936. [Abstract] [Full Text] [PDF]

				J. M. Hoffman, N. D. Shah, L. C. Vermeulen, F. Doloresco, P. Grim, R. J. Hunkler, K. M. Hontz, and G. T. Schumock Projecting future drug expenditures--2008 Am. J. Health Syst. Pharm., February 1, 2008; 65(3): 234 - 253. [Abstract] [Full Text] [PDF]

				A. Catlin, C. Cowan, M. Hartman, S. Heffler, and the National Health Expenditure Accounts Team National Health Spending In 2006: A Year Of Change For Prescription Drugs Health Aff., January 1, 2008; 27(1): 14 - 29. [Abstract] [Full Text] [PDF]

Comments: